Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in the Netherlands / NCT06248762
Recruiting Not applicable

PPI and Mindfulness App for Parents of Children with a NDD

NCT06248762 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2024-12-03
Last updated
2025-02-21

Condition(s) studied

StressMental HealthMental Well-being

Investigational drug(s) / intervention(s)

Adappt

Adappt: An app to support parents of children with a NDD

Study summary

An app based on positive psychology and mindfulness to support the mental well-being of parents of children with a Neurodevelopmental Disorder (NDD) was developed and will be evaluated on effectiveness.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. at least 18 years 2. parent of one or more children (\< 18 years) diagnosed with or suspected of a NDD 3. having access to internet 4. in possession of an e-mail address, 5. in possession of a smartphone or tablet 6. willing to use the digital intervention for a month, daily for approximately 15 minutes a day. Exclusion Criteria: 1. presence of severe anxiety symptoms 2. presence of moderately severe to severe depressive symptoms 3. being in treatment for mental health issues (the parent self)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Twente Enschede Netherlands Recruiting

More University of Twente trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06248762 on ClinicalTrials.gov ↗ ← All trials in the Netherlands